Trade Mark Journal No.2025/051 19 December 2025
WO0000001889189 (5,42)
Office of origin: United States of America
Date of International Registration:7 November 2025
Date of designation in the UK:
7 November 2025

International priority date claimed: 20 May 2025
(United States of America)
(99194756)
- Class 5
- Pharmaceutical products.
- Class 42
- Pharmaceutical research and development.
Exelixis, Inc.
Representative: Anessa Kramer Honigman LLP, 39400 Woodward Avenue, Suite 101, Bloomfield Hills MI 48304-5151, UNITED STATES OF AMERICA